Stocktoria
BioRestorative Therapies, Inc. BRTX
Nasdaq · XNAS · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2001-07-11
BioRestorative Therapies, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 93.4% | 93.0% | 100.0% | — | — |
| Operating margin | -4350.1% | -2881.6% | -10439.5% | -15838.1% | -57191.0% |
| Net margin | -3959.4% | -2239.2% | -7145.2% | -15438.0% | -96311.5% |
| FCF margin | -3031.7% | -2078.9% | -4527.6% | -5157.2% | -7305.6% |
| Return on assets | -349.1% | -73.1% | -82.6% | -112.5% | -197.3% |
| Return on equity | -3992.2% | -105.3% | -104.1% | -179.7% | -205.1% |
| Debt / equity | — | — | — | — | 0.01× |
| Current ratio | 0.84 | 2.97 | 4.37 | 34.36 | 59.01 |
| Revenue growth | -10.3% | 175.0% | 21.7% | 160.4% | -40.3% |
Source: SEC EDGAR filings · CIK 0001505497 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.